A novel molecular marker for early detection and evaluating prognosis of gastric cancer: N-myc downstream regulated gene-1 (NDRG1)

Scandinavian Journal of Gastroenterology

Volumn 45, Issue 7-8, 2010, Pages 898-908

  Jiang, Kewei ^a   Shen, Zhanlong ^a   Ye, Yingjiang ^a   Yang, Xiaodong ^a   Wang, Shan ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Apoptosis; Gastric cancer; Invasion; Metastasis; NDRG1; Proliferation

Indexed keywords

FORMALDEHYDE; MESSENGER RNA; MOLECULAR MARKER; PARAFFIN;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CELL GROWTH; CELL MOTILITY; CELL PROLIFERATION; CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; EARLY DIAGNOSIS; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; N MYC DOWNSTREAM REGULATED GENE 1; ONCOGENE C MYB; PRIORITY JOURNAL; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; STOMACH CANCER;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CELL CYCLE PROTEINS; DOWN-REGULATION; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; PROGNOSIS; STOMACH NEOPLASMS;

EID: 77955667474     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365520903242580     Document Type: Article

References (38)

1. Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999;83:18-29. (Pubitemid 29409471)
2. Bozzetti F, Bonfanti G, Morabito A, Bufalino R, Menotti V, Andreola S, et al. A multifactorial approach for the prognosis of patients with carcinoma of the stomach after curative resection. Surg Gynecol Obstet 1986;162:229-234
3. Adachi Y, Mori M, Maehara Y, Sugimachi K. Dukes's classification: a valid prognostic indicator for gastric cancer. Gut 1994;35:1368-1371
4. Maruyama K. The most important prognostic factors for gastric cancer patients: a study using univariate and multivariate analyses. Scand J Gastroenterol 1987;22:63-68
5. Yasui W, Oue N, Kuniyasu H, Ito R, Tahara E, Yokozaki H. Molecular diagnosis of gastric cancer: present and future. Gastric Cancer 2001;4:113-121
6. Lachat P, Shaw P, Gebhard S, van Belzen N, Chaubert P, Bosman FT. Expression of NDRG1, a differentiation related gene, in human tissues. Histochem Cell Biol 2002;118: 399-408.
7. Zhou RH, Kokame K, Tsukamoto Y, Yutani C, Kato H, Miyata T. Characterization of the human NDRG gene family:a newly identified member, NDRG4, is specifically expressed in brain and heart. Genomics 2001;73:86-97.
8. Park H, Adams MA, Lachat P, Bosman F, Pang SC, Graham CH. Hypoxia induces the expression of a 43-kDa protein (PROXY-1) in normal and malignant cells. Biochem Biophys Res Commun 2000;276:321-328
9. Kurdistani SK, Arizti P, Reimer CL, et al. Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage. Cancer Res 1998;58:4439-4444
10. Daigo Y, Nishiwaki T, Kawasoe T, Tamari M, Tsuchiya E, Nakamura Y. Molecular cloning of a candidate tumor suppressor gene, DLC1, from chromosome 3p21.3. Cancer Res 1999;59:1966-1972
11. Shimono A, Okuda T, Kondoh H. N-myc-dependent repression of ndr1, a gene identified by direct subtraction of whole mouse embryo cDNAs between wild type and N-myc mutant. Mech Dev 1999;83:39-52.
12. Cangul H, Salnikow K, Yee H, Zagzag D, Commes T, Costa M. Enhanced overexpression of an HIF-1/hypoxiarelated protein in cancer cells. Environ Health Perspect 2002; 110:783-788
13. Gómez-Casero E, Navarro M, Rodríguez-Puebla ML, Larcher F, Paramio JM, Conti CJ, Jorcano JL. Regulation of the differentiation-related gene drg-1 during mouse skin carcinogenesis. Mol Carcinog 2001;32:100-109.
14. Bandyopadhyay S, Pai SK, Gross SC, Hirota S, Hosobe S, Miura K, et al. The Drg-1 gene suppresses tumor metastasis in prostate cancer. Cancer Res 2003;63:1731-1736
15. Guan RJ, Ford HL, Fu Y, Li Y, Shaw LM, Pardee AB. Drg-1 as a differentiation - related, putative metastatic suppressor gene in human colon cancer. Cancer Res 2000;60: 749-755
16. Wang Z, Wang F, Wang WQ, Gao Q, Wei WL, Yang Y, Wang GY. Correlation of N-myc downstream-regulated gene 1 overexpression with progressive growth of colorectal neoplasm. World J Gastroenterol 2004;10:550-554
17. Lachat P, Shaw P, Gebhard S, van Belzen N, Chaubert P, Bosman FT. Expression of NDRG1, a differentiation-related gene, in human tissues. Histochem Cell Biol 2002;118: 399-408.
18. Arao T, Yanagihara K, TakigahiraM, Takeda M, Koizumi F, Shiratori Y, Nishio K. ZD6474 inhibits tumor growth and intraperitoneal dissemination in a highly metastatic orthotopic gastric cancer model. Int J Cancer 2006;118:483-489
19. Wang SN, Yeh YT, Yang SF, Chai CY, Lee KT. Potential role of leptin expression in hepatocellular carcinoma. J Clin Pathol 2006;59:930-934
20. Tomlinson IP, Bodmer WF. Failure of programmed cell death and differentiation as causes of tumors: some simple mathematical models. Proc Natl Acad Sci USA 1995;92: 11130-11134
21. Sager R. Expression genetics in cancer: shifting the focus from DNA to RNA. Proc Natl Acad Sci USA 1997;94:952-955
22. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996;87:159-170
23. Zhao P, Hu YC, Talbot IC. Expressing patterns of p16 and CDK4 correlated to prognosis in colorectal carcinoma. World J Gastroenterol 2003;9:2202-2206
24. Bandyopadhyay S, Pai SK, Hirota S, Hosobe S, Takano Y, Saito K, et al. Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression. Oncogene 2004;23:5675-5681 (Pubitemid 39093045)
25. Shah MA, Kemeny N, Hummer A, Drobnjak M, Motwani M, Cordon-Cardo C, et al. Drg1 expression in 131 colorectal liver metastases: correlation with clinical variables and patient outcomes. Clin Cancer Res 2005;11: 3296-3302
26. van Belzen N, Dinjens WN, Diesveld MP, Groen NA, van der Made AC, Nozawa Y, et al. A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms. Lab Invest 1997;77: 85-92.
27. Maruyama Y, Ono M, Kawahara A, Yokoyama T, Basaki Y, Kage M, et al. Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/ NDRG1/Drg-1 through modulation of angiogenesis. Cancer Res 2006;66:6233-6242
28. Bandyopadhyay S, Pai SK, Hirota S, Hosobe S, Tsukada T, Miura K, et al. PTEN up-regulates the tumor metastasis suppressor gene Drg-1 in prostate and breast cancer. Cancer Res 2004;64:7655-7660 (Pubitemid 39446890)
29. Stein S, Thomas EK, Herzog B, Westfall MD, Rocheleau JV, Jackson RS 2nd, et al. NDRG1 is necessary for p53-dependent apoptosis. J Biol Chem 2004;279:48930-48940
30. Liu YN, Lee WW, Wang CY, Chao TH, Chen Y, Chen JH. Regulatory mechanisms controlling human E-cadherin gene expression. Oncogene 2005;24:8277-8290
31. Maruyama Y, Ono M, Kawahara A, Yokoyama T, Basaki Y, Kage M, et al. Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/ NDRG1/Drg-1 through modulation of angiogenesis. Cancer Res 2006;66:6233-6242
32. Bandyopadhyay S, Wang Y, Zhan R, Pai SK, Watabe M, Iiizumi M, et al. The tumor metastasis suppressor gene Drg-1 down-regulates the expression of activating transcription factor 3 in prostate cancer. Cancer Res 2006;66:11983-11990
33. Cangul H. Hypoxia upregulates the expression of the NDRG1 gene leading to its overexpression in various human cancers. BMC Genet 2004;5:27.
34. Wang Z, Wang F, Wang WQ, Gao Q, Wei WL, Yang Y, Wang GY. Correlation of N-myc downstream-regulated gene 1 overexpression with progressive growth of colorectal neoplasm. World J Gastroenterol 2004;10:550-554
35. Yan X, Chua MS, Sun H, So S. N-Myc down-regulated gene 1 mediates proliferation, invasion, and apoptosis of hepatocellular carcinoma cells. Cancer Lett 2008;262: 133-142
36. Sutherland RM. Tumor hypoxia and gene expression implications for malignant progression and therapy. Acta Oncol 1998;37:567-574
37. Sprague LD, Mengele K, Schilling D, Geurts-Moespot A, Sweep FC, Stadler P, et al. Effect of reoxygenation on the hypoxia-induced up-regulation of serine protease inhibitor PAI-1 in head and neck cancer cells. Oncology 2006;71: 282-291
38. Calzada MJ, del Peso L. Hypoxia-inducible factors and cancer. Clin Transl Oncol 2007;9:278-289